TMI Sports Medicine & Orthopedic Surgery is proud to partner with Greyledge Technologies, a leader in regenerative biologic therapies. This collaboration reflects our ongoing commitment to providing the most advanced, evidence-based treatments to help our patients recover faster and perform at their best.
Greyledge Technologies has revolutionized the field of orthobiologics by developing precise, lab-based methods for processing autologous whole blood and bone marrow tissue. Unlike many regenerative medicine solutions, Greyledge’s preparations are customized, quantified, and quality-controlled—ensuring the highest standards of safety and effectiveness.
Through this partnership, TMI physicians can now offer advanced Platelet-Rich Plasma (PRP) and Bone Marrow Concentrate (BMC) therapies that are tailored to each individual patient. Every preparation is analyzed prior to use, giving both patients and providers confidence in the product’s composition and performance.
Together, TMI and Greyledge Technologies are elevating the standard of care in regenerative medicine—supporting healing at the cellular level and empowering patients with innovative, biologically sound treatment options.
